Peshwa
SENIOR MEMBER
- Joined
- Jun 26, 2009
- Messages
- 4,918
- Reaction score
- -10
- Country
- Location
Not the equipment, the active ingridients.
Can you name 3 manufactures of Penicillin-G in India ? Not distributors, people who actually manufacture it and sell it. Not people who resale it after buying it from China.
Name the company and where its manufactured.
China leads in the non-regulated market (low margins, Low regulations and low quality), however China cannot and does not compete with India in the regulated markets like the US.
Out of the products you mentioned, Unique Pharma (part of JB Chemicals) makes, Ciprofloxicin, Metformin and Ranitidine APIs. (PM me seperately if you want more information or want to talk about other products)
90% is an exaggeration. Indian pharma companies are quite advanced and maintain high quality standards (cGMP) and FDA approved plants. They heavily cater to the US market and the heavy regulation that comes with leads to higher costs.
Indian companies also tend to focus on formulation (US market) than API trade. Nevertheless, even within formulation, Indian companies are starting to vertically and backward integrate for formulations. So they produce for captive requirement and not so much API trade. So the issue of china closing the "tap" and its intended consequences is highly exaggerated.
India is an unregulated market, and hence it is cheaper to buy from china...nevertheless, this does not mean that if china stops supply that somehow India will suffer. Indian manufacturers will fill the void in the market which is currently not profitable for them given the low margins. They prefer the US market and focus on it (most of them).
Last edited: